Valid cardiac biomarkers. Part I
Biomarkers are widely used for the diagnosing of diseases, evaluation of their severity, prediction of outcomes, and for monitoring the effectiveness and safety of targeted therapy. This review describes specific cardiac biomarkers approved by FDA (Food and Drug AdministrationбUSA). The list of desc...
Saved in:
Main Authors: | V. A. Metelskaya, N. G. Gumanova |
---|---|
Format: | Article |
Language: | Russian |
Published: |
«SILICEA-POLIGRAF» LLC
2020-09-01
|
Series: | Кардиоваскулярная терапия и профилактика |
Subjects: | |
Online Access: | https://cardiovascular.elpub.ru/jour/article/view/2573 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Valid cardiac biochemical markers. Part II
by: N. G. Gumanova, et al.
Published: (2020-11-01) -
Associations of circulating biomarkers with the presence and severity of coronary, carotid and femoral arterial atherosclerosis
by: V. A. Metelskaya, et al.
Published: (2022-01-01) -
Prediction of coronary atherosclerosis in young patients with coronary artery disease using a non-invasive biomarker
by: V. E. Oleinikov, et al.
Published: (2020-12-01) -
The potential role of miRNAs in calcification of cardiovascular diseases
by: A. G. Ibragimova, et al.
Published: (2019-11-01) -
Conventional risk factors and arterial bed parameters in patients with coronary artery disease younger and older than 50 years
by: A. A. Khromova, et al.
Published: (2020-09-01)